Velaglucerase Alfa

Category: Enzymes

Velaglucerase Alfa Overview

Velaglucerase alfa (trade name VPRIV), manufactured by Shire plc is a hydrolytic lysosomal glucocerebroside-specific enzyme, which is a recombinant form of glucocerebrosidase indicated as a long-term enzyme replacement therapy for those suffering of Gaucher disease Type 1. It has an identical amino acid sequence to the naturally occurring enzyme.[1] It was approved for use by the U.S. Food and Drug Administration (FDA) on February 26, 2010.[2] Competitive pr...

Read more Velaglucerase Alfa Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Velaglucerase_alfa

Recent Velaglucerase Alfa Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Velaglucerase Alfa

Injection: 200units, 400 units/vial, 400units
Powder: 200 units/vial

Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Velaglucerase Alfa or a similar ingredient: (1 result)

VPRIV Velaglucerase Alfa